Detalhe da pesquisa
1.
Early molecular diagnosis of BRAF status drives the neurosurgical management in BRAF V600E-mutant pediatric low-grade gliomas: a case report.
BMC Pediatr
; 22(1): 685, 2022 11 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-36447197
2.
The role of pharmacies in haematopoietic stem cell transplantation process: A nationwide survey by Gruppo Italiano Trapianto di Midollo Osseo.
J Clin Pharm Ther
; 46(6): 1665-1679, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34397108
3.
AmBisome® Formulations for Pediatrics: Stability, Cytotoxicity, and Cost-Effectiveness Studies.
Pharmaceutics
; 16(4)2024 Mar 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-38675127
4.
Mini-Tablets: A Valid Strategy to Combine Efficacy and Safety in Pediatrics.
Pharmaceuticals (Basel)
; 15(1)2022 Jan 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-35056165
5.
Current and promising therapeutic options for Dravet syndrome.
Expert Opin Pharmacother
; 23(15): 1727-1736, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-36124778
6.
Dyslipidemia in Children Treated with a BRAF Inhibitor for Low-Grade Gliomas: A New Side Effect?
Cancers (Basel)
; 14(11)2022 May 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-35681673
7.
Outcomes of BRAF V600E Pediatric Gliomas Treated With Targeted BRAF Inhibition.
JCO Precis Oncol
; 42020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32923898